Copper metallodendrimers effectively deliver proapoptotic siRNA to human liver carcinoma HepG2 cells
- 6 July 2026
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 701, 127145
Abstract
No abstract availableKeywords
Funding Information
- Narodowe Centrum Nauki
- HORIZON EUROPE Framework Programme
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina
- Ministerio de Ciencia, Innovación y Universidades
- Universidad de Alcalá
- Junta de Comunidades de Castilla-La Mancha
This publication has 40 references indexed in Scilit:
- Copper-Based biomaterials for anti-tumor therapy: Recent advances and perspectivesActa Biomaterialia, 2025
- Gene silencing by RNA interference: a reviewGenome Instability & Disease, 2024
- Cancer metastases: Tailoring the targetsHeliyon, 2024
- Unveiling the promising anticancer effect of copper-based compounds: a comprehensive reviewJournal of Cancer Research and Clinical Oncology, 2024
- Apoptosis induction capability of silver nanoparticles capped with Acorus calamus L. and Dalbergia sissoo Roxb. Ex DC. against lung carcinoma cellsHeliyon, 2024
- Poly (propylene imine) dendrimer as an emerging polymeric nanocarrier for anticancer drug and gene deliveryEuropean Polymer Journal, 2021
- Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancerEuropean Journal of Medicinal Chemistry, 2020
- Phosphorus dendrimers as powerful nanoplatforms for drug delivery, as fluorescent probes and for liposome interaction studies: A concise overviewEuropean Journal of Medicinal Chemistry, 2020
- Anticancer activity of a series of copper(II) complexes with tripodal ligandsEuropean Journal of Medicinal Chemistry, 2017
- Activation of apoptosis signalling pathways by reactive oxygen speciesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016